Avaí Bio, Inc. (AVAI)

OTCMKTS · Delayed Price · Currency is USD
0.3670
-0.0310 (-7.79%)
Mar 4, 2026, 11:18 AM EST
Market Cap55.01M -32.2%
Revenue (ttm)n/a
Net Income-1.03M
EPS-0.01
Shares Out138.25M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,500
Average Volume81,557
Open0.3701
Previous Close0.3980
Day's Range0.3670 - 0.3701
52-Week Range0.2191 - 0.8277
Beta0.86
RSI41.00
Earnings DateFeb 10, 2026

About Avaí Bio

Avaí Bio, Inc. acquires, creates, and develops artificial intelligence (AI) technologies. It also offers information technology (IT) consulting services. The company provides full-stack software development, database management, data integration, project management and cloud services resources. Further, it offers Avant! AI, a platform that has shown impressive results related to the technology’s usage, access, and performance; and InstantFAME. The company was formerly known as Avant Technologies Inc. and changed its name to Avaí Bio, Inc. in Fe... [Read more]

Sector Technology
Founded 2017
Employees 2
Stock Exchange OTCMKTS
Ticker Symbol AVAI
Full Company Profile

Financial Performance

Financial Statements